title: Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people.
abstract: OBJECTIVE
  Low-grade chronic inflammation is associated with risk for type 2 diabetes. We investigated the associations between inflammatory factors and glycaemic status in a middle-aged and older Chinese population.
  
  
  METHODS
  A population-based cross-sectional study of 3289 residents aged 50-70 years from Beijing and Shanghai.
  
  
  METHODS
  C-reactive protein (CRP), interleukin-6 (IL-6) and soluble tumour necrosis factor alpha-receptor two (sTNFR2) were assayed.
  
  
  RESULTS
  Comparing the highest with the lowest quartile of CRP, the odds ratio (OR) of diabetes was significantly higher in women [3.66 (95% CI 2.23-6.03)] than in men [1.51 (0.95-2.41)] (P for interaction = 0.004), while the increased OR for impaired fasting glucose (IFG) was only observed in women [OR 2.03 (1.44-2.84)] (P for interaction = 0.022), after adjustment for age, geographic location, education, lifestyle factors, family history of diabetes, and use of antibiotics, aspirin and lipid-lowering drugs. The multiple-adjusted OR of IL-6 for diabetes was also higher in women [2.95 (1.78-4.90)] than in men [2.23 (1.39-3.59)] (P for interaction = 0.045). sTNFR2 was not associated with diabetes but inversely associated with IFG in men [OR 0.59 (0.41-0.85)] and women [OR 0.78 (0.56-1.09)] (P for interaction = 0.13). In addition, CRP was significantly associated with increased HbA(1c) in both genders within euglycaemia after multiple adjustments.
  
  
  CONCLUSIONS
  Inflammatory markers are closely associated with diabetes and IFG in Chinese people. These associations appear to be stronger in women than in men. Furthermore, plasma CRP is positively associated with HbA(1c) even in euglycaemic individuals.
authors.affiliation: Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Graduate School of the Chinese Academy of Sciences, Shanghai, China.
authors.forename: Xingwang
authors.initials: X
authors.lastname: Ye
authors.forename: Oscar H
authors.initials: OH
authors.lastname: Franco
authors.forename: Zhijie
authors.initials: Z
authors.lastname: Yu
authors.forename: Huaixing
authors.initials: H
authors.lastname: Li
authors.forename: Frank B
authors.initials: FB
authors.lastname: Hu
authors.forename: Huaiyu
authors.initials: H
authors.lastname: Liu
authors.forename: Xiangdong
authors.initials: X
authors.lastname: Wang
authors.forename: Haiying
authors.initials: H
authors.lastname: Tang
authors.forename: Yong
authors.initials: Y
authors.lastname: Liu
authors.forename: Yan
authors.initials: Y
authors.lastname: Chen
authors.forename: Xu
authors.initials: X
authors.lastname: Lin
mesh_terms: D000368:Aged; D044466:Asian People / Q000706:statistics & numerical data; D001786:Blood Glucose; D002097:C-Reactive Protein / Q000276:immunology*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000276:immunology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood* / Q000276:immunology; D018836:Inflammation Mediators / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000097:blood* / Q000276:immunology
chemical_list: D001786:Blood Glucose; D007074:Immunoglobulin G; D018836:Inflammation Mediators; D015850:Interleukin-6; D018124:Receptors, Tumor Necrosis Factor; D002097:C-Reactive Protein; D000068800:Etanercept